Purine compounds used as CB2 agonists

Details for Australian Patent Application No. 2011235290 (hide)

Owner Eli Lilly and Company

Inventors Hollinshead, Sean Patrick

Agent Spruson & Ferguson

Pub. Number AU-A-2011235290

PCT Pub. Number WO2011/123482

Priority 61/319,532 31.03.10 US

Filing date 30 March 2011

Wipo publication date 6 October 2011

International Classifications

C07D 473/34 Heterocyclic compounds containing purine ring systems

A61K 31/52

A61P 25/06 Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/123482 Priority application(s): WO2011/123482

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235292-Adjustable intraocular lens system

2011235286-Systems and methods of providing foot operated latching